List of Medications Contraindicating Receipt of Smallpox Vaccine
The ACIP recommends that individuals taking medications in certain pharmacologic categories not be vaccinated with the smallpox vaccine. There is concern that enhanced vaccinia virus replication due to medication-induced immunosuppression may occur, leading to the possibility of untoward effects of the virus in the person taking these medications.
General categories of medications that are considered immunosuppressive
- Alkylating agents
- Antimetabolites, or
- High-dose corticosteroids (> 2 mg/kg body weight or 20 mg/day of prednisone for > 2 weeks).
- Other immunosuppressive medications, immune suppressing antibodies and interferons
The categories of medications include those used to directly treat cancers and those that adversely affect the immune system (at recommended doses/duration or greater). Corticosteroids used in greater than physiologic doses may reduce the immune response to the vaccine. Persons being treated with or taking high dose corticosteroids should not be vaccinated with the smallpox vaccine within one month of completing corticosteroid therapy, and persons being treated with other immunosuppressive drugs within the prior 3 months should not be vaccinated.
The attached list is for general guidance about medications that if an individual is taking may contraindicate them from receiving the smallpox vaccine This list is not meant to be exhaustive but to serve as a guide to clinicians seeking to assist patients decide if they should be vaccinated with the smallpox vaccine. One should note that certain other medications not listed, may idiosyncratically and in certain health conditions, be immunosuppressive. Therefore clinical judgment is needed to decide the impact of these medications for patients based on their health status.
The medications are listed in alphabetic order of their generic names.
Contributors to the development of this document
Charles C. Thomas, R. Ph., FAPhA
State Pharmacy Director
Alabama Department of Public Health
Seymour Williams, MD
Medical Epidemiologist
Smallpox Preparedness and Response Activity
National Immunization Program, MS E-05
Centers for Disease Control and Prevention
GENERIC DRUG | BRAND NAME DRUG | CATEGORY |
*EQUIVALENCY NUMBER TO PREDNISONE |
---|---|---|---|
Abacavir | Ziagen® | T |
|
Abciximab | ReoPro® | M |
|
Adalimumab | Humira | DMARD |
|
Aldesleukin | Interleukin 2® | A |
|
Altretamine | Hexalen | A |
|
Aminoglutethimide | Cytadren | A |
|
Amprenivir | Agenerase® | T |
|
Anakinra | Kineret® | D |
|
Anastrozole | Arimidex | A |
|
Asparaginase | Elspar® | A |
|
Azathioprine | Imuran® | I |
|
Basiliximab | Simulect® | M |
|
Betamethasone | Celestone® | C |
0.12 |
Betamethasone | Valisone® | C |
0.12 |
Bleomycin | Blenoxane® | A |
|
Busulfan | Myleran® | A |
|
Capecitabine | Xeloda | A |
|
Carboplatin | Paraplatin® | A |
|
Carmustine | BiCNU® (BCNU) | A |
|
Chlorambucil | Leukeran® | A |
|
Cidofovir | Vistide® | T |
|
Cisplatin | cis-diamminedichloroplatinum II [cDDP] | A |
|
Cisplatin | Platinol® | A |
|
Cladribine | Leustatin® | A |
|
Cortisone | Cortone® | C |
5 |
Cyclophosphamide | CTX | A |
|
Cyclophosphamide | Cytoxan® | A |
|
Cyclophosphamide | Neosar | A |
|
Cyclosporine | Neoral® | I |
|
Cyclosporine | Sandimmune® | I |
|
Cytarabine | ara-C | A |
|
Cytarabine | Cytosar-U® | A |
|
Cytarabine | DepoCyt | A |
|
Dacarbazine | DTIC-Dome® | A |
|
Dacarbazine | Imidazole Carboxamide | A |
|
Daclizumab | Zenopax | M |
|
Dactinomycin | Cosmegan® | A |
|
Daunorubicin | Cerubidine® | A |
|
Daunorubicin | Daunomycin | A |
|
Daunorubicin | Daunoxome® | A |
|
Daunorubicin | Rubidomycin | A |
|
Delavirdine | Rescriptor® | T |
|
Denileukin diftitox | Ontak | A |
|
Dexamethasone | Decadron® | C |
|
Didanosine | Videx® | T |
|
Docetaxel | Taxotere | A |
|
Doxorubicin | Adriamycin | A |
|
Doxorubicin | Doxil® | A |
|
Doxorubicin | Hydroxydaunorubicin | A |
|
Doxorubicin | Rubex | A |
|
Efavirenz | Sustiva® | T |
|
Epirubicin | Ellence | A |
|
Estramustine | Emcyt | A |
|
Etanercept | Enbrel® | D |
|
Etoposide | Etopophos® | A |
|
Etoposide | VePesid® | A |
|
Exemestane | Aromasin | A |
|
Floxuridine | Fluorodeoxyuridine | A |
|
Floxuridine | FUDR® | A |
4 |
Fludarabine | FAMP | A |
4 |
Fludarabine | Fludara® | A |
4 |
Fluorouracil | 5-FU® | A |
|
Fluorouracil | Adrucil | A/Derm |
4 |
Fluorouracil | Efudex® | A/Derm |
|
Flutamide | Eulexin® | A |
|
Gemcitabine | Gemzar | A |
|
Gemtuzumab ozogamicin | Mylotarg | AI |
|
Hydrocortisone | Cortef® | C |
|
Hydrocortisone | Hydrocortone® | C |
|
Hydroxychloroquine | Plaquenil® | T |
|
Hydroxyurea | Hydrea® | A |
|
Idarubicin | Idamycin | A |
|
Ifosphamide | Ifex® | A |
|
Indinavir | Crixivan® | T |
|
Infliximab | Remicade® | M |
|
Interferon alfa-2a | Roferon-A® | A |
|
Interferon alfa-2b | Intron-A® | A |
|
Interferon beta-1a | Avonex® | AV |
|
Interferon beta-1b | Betaseron® | AV |
|
Interferon gamma-1b | Actimmune® | A |
|
Interleukin-2 | Aldesleukin | AI |
|
Interleukin-2 | Proleukin | AI |
|
Irinotecan | Camptosar | A |
|
Isotretinoin | Accutane | Aderm |
|
Lamivudine | Epivir® | T |
|
Lamivudine & Zidovudine | Combivir® | T |
|
Leflunomide | Arava® | D |
|
Letrozole | Femara | A |
|
Leuprolide | Lupron® | A |
|
Lomustine | CeeNu® (CCNU) | A |
|
Mechlorethamine HCI | Mustargen® | A |
|
Mechlorethamine HCI | Nitrogen Mustard | A |
|
Megestrol | Megace® | A |
|
Melphalan | Alkeran® | A |
0.8 |
Melphalan | L-Phenylalanine Mustard | A |
|
Melphalan | L-Sarcolysine | A |
|
Mercaptopurine | Purinethol® | A |
|
Methotrexate | Amethopterin | A |
|
Methotrexate | Mexate | A |
|
Methotrexate | Rheumatrex® | D |
|
Methotrexate | Trexall™ | D |
|
Methylprednisolone | Medrol® | C |
|
Mitomycin | Mutamycin® | A |
|
Mitotane | Lysodren® | A |
|
Mitoxantrone | Dihydroxyanthracenedione | A |
|
Mitoxantrone | Novantrone | A |
|
Muromonab-CD3 | Orthoclone-OKT3 | M |
|
Mycophenolate | Cellsept® | I |
|
Nelfinavir | Viracept® | T |
|
Nevirapine | Viramune® | T |
|
Paclitaxel | Taxol® | A |
|
Pegaspargase | Oncaspar® | A |
1 |
Penicillamine | Cuprimine® | D |
1 |
Pentostatin | Nipent® | A |
1 |
Pimecrolimus | Elidel | Derm |
|
Pipobroman | Vercyte® | A |
1 |
Plicamycin | Mithracin® | A |
1 |
Prednisolone | Pediapred® | C |
1 |
Prednisolone | Prelone® | C |
|
Prednisone | DeltaCortef® | C |
|
Prednisone | Deltasone® | C |
|
Prednisone | Meticorten® | C |
|
Prednisone | Sterapred® | C |
|
Priliximab | Centara | M |
|
Procarbazine | Matulane® | A |
|
Procarbazine | Natulanar | A |
|
Procarbazine | N-Methylhydrazine | A |
|
Ritonavir | Norvir® | T |
|
Rituximab | Rituxan | AI |
|
Saquinavir | Fortovase® | T |
|
Saquinavir | Invirase® | T |
|
Sargramostim | Leukine | I |
|
Sargramostim | Leukomax | I |
|
Stavudine | Zerit® | T |
|
Streptozocin | Zanosar® | A |
|
Tacrolimus | Prograf® | I |
|
Temozolomide | Temodar | A |
|
Teniposide | VM-26® | A |
|
Teniposide | Vumon® | A |
|
Testolactone | Teslac® | A |
|
Thioguanine | 6-TG® | A |
|
Thioguanine | Aminopurine-6-Thiol-Hemihydrate | A |
|
Thioguanine | Lavis | A |
0.8 |
Thioguanine | Tabloid | A |
|
Thiotepa | TESPA (TSPA) | A |
|
Thiotepa | Thioplex® | A |
|
Thiotepa | Triethylenethiophosphoramide | A |
|
Trastuzumab | Herceptin | AI |
|
Tretinoin | All-Trans Retinoic Acid | A |
|
Tretinoin | Vesanoid | A |
|
Triamcinolone | Kenalog® | C |
|
Uracil mustard | Uracil Mustard | A |
|
Valrubicin | Valstar® | A |
|
Vinblastine | Velban® | A |
|
Vinblastine | Velsar | A |
|
Vincristine | Oncovin® | A |
|
Vinorelbine | Navelbine® | A |
|
Zalcitabine | Hivid® | T |
|
Zidovudine | AZT® | T |
|
Zidovudine | Retrovir® | T |
KEY
A = Antineoplastic Agent
AV = Antiviral Agent
C = Corticosteroid
D = DMARD
(Disease Modifying Anti-Rheumatic Drug)
I = Immunosuppressive
M = Monoclonal
Antibody Drug
T = treats immunosuppressive diseases or used for them prophylactically
Derm
= Dermatologic use
*Equivalency Number To Prednisone = represents a number
which when divided into the dose of a similar drug will yield a dose that
is approximately equal to the prednisone dosage.
Sources:
- American Hospital Formulary Service, 1996
- Pharmacist's Handbook of Drugs, ASHP 2001 Edition
- Package Insert, Dryvax Smallpox Vaccine, Wyeth Labs, published August 30, 2002
- CDC, Advisory Committee of Immunization Practices
- Drug Information Handbook, Lexicomp, 6th Edition
- Grabenstein JD. ImmunoFacts: Vaccine and Immunologic Drugs. St. Louis: Facts and Comparisons, 2002
- Lippincott Williams & Wilkins: LWW ONCOLOGY
- Page last reviewed February 7, 2007
- Page last updated April 25, 2003
- Content source: Division of Bioterrorism Preparedness and Response (DBPR), National Center for Preparedness, Detection, and Control of Infectious Diseases (NCPDCID), Coordinating Center for Infectious Diseases (CCID)
Get email updates
To receive email updates about this page, enter your email address:
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348
24 Hours/Every Day - cdcinfo@cdc.gov